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Abstract 
Background: Early readmissions following hospital discharge for heart failure (HF) remain a major concern. Among the 
various strategies designed to reduce readmissions, home evaluations have been observed to have a favorable impact. We 
assessed the feasibility of integrating community paramedics into the outpatient management of HF patients. 
Methods: Selected paramedics completed an educational HF curriculum. These Mobile Integrated Health Paramedics 
(MIHP) performed scheduled home visits 2- and 15-days post-discharge for patients with Stage C HF (Phase I) and 
patients with Stage D HF (Phase II). Facilitated by a Call Center, a process was created for performing urgent MIHP 
house calls within 60 minutes of a medical provider’s request. A HF specialist, with an on-call emergency department 
command physician, could order an intravenous diuretic during home visits. During each phase of the study the incidence 
of 30-day HF readmissions, 30-day all-cause readmissions, emergency room evaluations, unplanned office encounters, as 
well as any adverse events were prospectively documented. 
Results: Collaborative relationships between our hospital network and local EMS organizations were created. There 
were 82 MIHP home visits. Eight patients received urgent home evaluations within 60 minutes post-request, 1 requiring 
transport to an ED. The incidence of all-cause 30-day readmissions in 20 Stage C and 20 Stage D patients was 15% and 
40%, respectively. There were no adverse events attributable to the MIHP house calls. 
Conclusions: It is feasible to integrate MIHPs into the outpatient management of HF. Signals of effectiveness for 
reducing early readmissions were observed. Obstacles to creating an effective paramedic “House Calls” program were 
identified. A randomized trial is required to assess the value of this care process and its impact on early readmissions in 
patients with Stage C and Stage D HF. 











The long-term prognosis of patients hospitalized with heart failure (HF) is poor with a combined 
readmission and mortality rate of 97% during 5-year follow up(1). A high percentage of patients with 
HF are readmitted early after an initial hospitalization(2), many occurring within the first 15 days of 
discharge(3). Multiple factors contribute to early readmissions with only one-third attributable to 
decompensated HF(4). Various methods to reduce 30-day all-cause and HF-specific readmissions 
have been evaluated. Patients undergoing an evaluation within 7 days, as opposed to 8 to 30 days 
after discharge were observed to have reduced 30-day readmissions(5). 
A retrospective review of 47 randomized trials compared the effectiveness of other methods to 
reduce hospital readmissions(6). Only one of these trials, using a high intensity home visiting 
program with advanced nurse practitioners, reported a reduction in all-cause 30-day 
readmissions(7). A small randomized pilot study employing in-home care provided by a traveling 
physician and a nurse observed a trend toward reduced emergency department (ED) visits as well 
as readmissions(8). These studies suggest in-home patient encounters, performed early post-
discharge with the option for home-based medical interventions, may be an effective method for 
reducing short-term readmissions. 
 In contrast, patient education followed by intermittent phone call assessments and nurse 
home visits performed 1 to 2 weeks post-discharge, although reported to reduce readmissions 
during extended follow up, did not have a favorable impact on 30-day readmissions(9,10), 
Telehealth, using technologies to transmit information from the patient’s home to a HF team, 
favorably impacted quality of life variables, but was not consistently associated with reduced early 
readmissions (11). Six large multicenter, randomized trials of home telemonitoring in >5,200 
patients did not reduce short-term readmission rates (12–17). As a consequence of these 
observations, routine use of remote monitoring is not recommended by the Heart Failure Society of 
America(18). Although HF management guided by telemonitoring of implanted hemodynamic 
devices significantly reduced 30-day, as well as long-term readmissions (19,20). cost has restricted 
utilization of these devices (21). New, safe and cost-effective alternatives to reduce short term 
readmissions are needed (22). 
Emergency medical service (EMS) organizations have formed partnerships with hospitals 
to provide home care with community paramedics and reported reduced readmissions and cost of 
care(23–26). These observational studies suggest community paramedics, working within a Mobile 
Integrated Health Paramedic (MIHP) program, have the capability of providing a timely response 
to patient concerns and, guided by physicians, the ability to provide acute medical interventions in 
the home environment. Although a randomized trial has been planned(27), to date there are no 
published randomized trials designed to assess the impact of a MIHP program on 30-day 
readmissions or cost of care. In anticipation of performing a randomized trial, we investigated the 
feasibility of integrating community paramedics into the outpatient management of patients with 
HF with scheduled and, if needed, urgent “house calls”. 
Methods 
 The study was conducted in the Lehigh and Northampton counties of Pennsylvania between 
August 2017 and December 2019. Only Pennsylvania-certified paramedics employed by one of the 
participating EMS agencies were eligible to participate. Professional service contracts between our 
hospitals and private EMS organizations were created. Participating paramedics were required to 
complete the Collaborative Institutional Training Initiative (CITI) for human subject research and 
an educational HF curriculum. All paramedics participating in this feasibility trial were required to 
attend educational sessions (Table 1). In addition, paramedics were required to complete the 










subjects in research. They were also required to spend time in a dedicated heart failure clinic, 
seeing patients with a nurse practitioner. Finally, before patient enrollment, paramedics were 
required to participate in a mock drill, performed in a classroom and a second mock drill in a 
private residence. These drills were designed to test their knowledge of the signs and symptoms of 
heart failure as well as to confirm their knowledge of appropriate documentation. The drills also 
tested the process of communication between a medical provider, the Call Center and the 
paramedics. 
Upon successful completion of the above requirements the paramedic was referred to as a 
MIHP. Paramedics were required to function within their scope of care defined by the 
Pennsylvania General Assembly's Title 35, Chapter 81 on the EMS System. In Pennsylvania, 
paramedics can only accept orders for interventions outside their state protocols from emergency 
department (ED) command physicians. A MIHP Call Center was created to assist with 
communications between paramedics, HF specialists and, if needed, an ED command physician. 
HF specialists included cardiologists and dedicated HF nurse practitioners. 
 Hospitalized patients were identified utilizing standardized definitions of HF(28–30). These 
definitions were particularly valuable for identification of patients with HF and preserved ejection 
fraction (EF), distinguishing them from those with dyspnea due to obesity or lung disease and from 
patients with edema due to venous insufficiency. Written consent was required for enrollment. The 
inclusion and exclusion criteria are available in the supplement. The patient’s participation in the 
trial began on the day of discharge and was terminated 30 days after discharge. Enrolled patients 
received usual care including outpatient clinic evaluations performed 5-7 days after discharge. 
Patients could receive home health care by a visiting nurse at the discretion of their HF specialist. 
In addition, each patient received a scheduled MIHP house call 2 and 15 days after hospital 
discharge. Physicians or nurse practitioners could request an urgent MIHP home evaluation any 
time during the first 30 days after patient enrollment. Urgent MIHP house calls, facilitated by the 
MIHP Call Center, were performed within 60 minutes. A HF specialist, in conjunction with the on-
call command physician, could order the MIHP to administer an intravenous diuretic or topical 
nitroglycerin during the home encounter. After administration of any medication, the MIHP 
provided monitoring for 60 minutes to detect acute beneficial and/or adverse effects. The patient, 
command physician or the HF specialist could request transport to a local hospital for an 
emergency evaluation at any time by calling 911. The study investigators encouraged transport to a 
local ED in response to persistent HR <40 or >130 bpm, RR >25/min, SpO2 <90% or clinical signs 
of respiratory failure(31). A HF specialist could request MIHP follow up house calls and additional 
medical interventions at the patient’s home on consecutive days. During each home visit the MIHP 
documented all information using a standardized electronic template. The documentation of each 
home encounter was entered into the patient’s electronic medical record (EMR). 
 The assessment of feasibility was performed in 2 phases. During Phase I, patients with Stage 
C HF were enrolled. During Phase II, patients with Stage D HF were enrolled. During each phase the 
incidence of 30-day HF readmissions, 30-day all-cause readmissions, emergency room evaluations, 
unplanned office encounters and any adverse events were prospectively documented. Readmission 
due to HF was defined as in-hospital care for >24 hours with intravenous diuretics, vasoactive or 
inotropic agents or the implementation of mechanical cardiac support. Patients on “observation” 
status meeting these criteria were categorized as a readmission. Written and phone call surveys were 
performed to assess patient, physician and nurse practitioner perceptions of the MIHP process of 
care. Any outcome perceived by patients, physicians, nurse practitioners or the MIHPs to be 
injurious or potentially detrimental to patient well-being was considered an adverse event. 
Descriptive statistics were used to describe patient attributes and outcomes at 30 days. The study was 
approved by the Lehigh Valley Health Network Institutional Review Board (Study PRO00004858). 










Patients 18 years of age or older, admitted the hospital with acute or acute on chronic heart 
failure (HF), Stage C (phase I) and Stage D (phase II), with New York Heart Association (NYHA) 
functional class (FC) II-IV who resided within the geographic boundaries of the participating 
emergency medical services were eligible to participate. Criteria for the diagnosis of HF and Stage of 
HF were based upon guidelines and consensus statements from the American College of Cardiology 
Foundation, American Heart Association, American Society of Echo and the European Society of 
Cardiology(28,29).
 
Criteria for HF with reduced left ventricular (LV) ejection fraction (HFrEF), 
included signs and symptoms of HF plus an LV EF ≤40%. Criteria for HF with intermediate or 
preserved LV ejection fraction (HFpEF), included signs and symptoms of HF, LV EF >40% plus one 
of the following: echo Doppler evidence of elevated (LV) filling pressure invasively measured 
pulmonary capillary wedge pressure >12 mmHg or LV end diastolic pressure >16 mmHg or a 
biomarker of HF with BNP level ≥400 pg/ml or NT-proBNP levels ≥450 pg/ml, >900 pg/ml and 
>1800 pg/ml based on age categories <50, 50-75 and >75, respectively (30). Stage C was defined as 
HF requiring hospitalization and the use of guideline directed medical therapy. Stage D was defined 
as advanced or refractory HF with persistent signs and symptoms despite guideline directed medical 
therapy (GDMT). These patients were required to have 2 or more of the following attributes: severe 
impairment in functional capacity (NYHA FC III-IV); greater than 2 hospitalizations or ED 
evaluations for HF in past year; progressive rise in BUN/creatinine; intolerance to GDMT due to 
hypotension or worsening renal function; Persistent systolic BP < 90 mmHg; recent need for 
escalating doses of loop diuretics equivalent to furosemide >80 mg/day and/or addition of 
metolazone; progressive decline in serum Na <133 meg/L; frequent ICD shocks; Doppler evidence 
of elevated LV filling pressure or PCWP > 16 mmHg; weight loss without other cause. Stage D 
patients could require specialized treatment strategies such as intermittent or continuous inotropic 
infusions, mechanical circulatory support, or hospice care. 
Exclusion criteria included severe valvular disease, pericardial constriction, severe 
precapillary pulmonary hypertension defined as pulmonary artery systolic pressure >60 mm Hg, 
mean trans-pulmonary gradient >15 mm Hg or pulmonary vascular resistance >6 Wood units; 
chronic kidney disease on dialysis, scheduled for re-hospitalization for a procedure within 30 days, 
receiving skilled nursing care prior to admission, severe cognitive impairment or a very low 
probability of survival during the next 6-12 months. Patient was unable or unwilling to participate in 
the study protocol for any reason were also excluded. 
Results 
Phase I Stage C HF 
  Collaborative relationships and written agreements between our hospital network and 
5 local EMS organizations were created. Nine paramedics completed CITI training and the 
educational curriculum. Twenty-five eligible patients were identified of which 20 agreed to 
participate (Table 2). Seven ED command physicians volunteered to be on-call 24/7 for Phase I of 
the trial. The outcomes at 30 days are summarized in Table 3. A total of 49 MIHP house calls were 
performed. Urgent in-home visits, requested by a HF specialist, were performed in 6 (30%) 
participants, one of whom was triaged to a local ED. Command physicians assisted with the order for 
home intravenous (IV) diuretics for 2 patients, one receiving IV diuretics on two consecutive days. 
Patient initiated ED evaluations were performed in 4 patients, of which 2 were admitted. Four 
patients underwent unplanned clinic visits. Four participants, including the 2 patients discharged 
after an ED evaluation, received follow up MIHP in-home visits. The incidence of 30-day all-cause 
readmissions was 15%. The incidence of HF readmissions was 5%. There were no adverse events. 
There were no deaths. Surveys of patients and HF specialists revealed a positive perception of the 
MIHP process of care. 










  Twenty patients with Stage D HF were identified and agreed to participate (Table 2). 
One ED command physician volunteered to be on-call 24/7 for Phase II. The outcomes at 30 days are 
summarized in Table 3. A total of 33 MIHP house calls were performed. Urgent home encounters 
were performed in 2 (10%) of the participants. One patient withdrew from the study prior to the first 
scheduled home visit. One patient elected to cancel their second scheduled MIHP house call after 
they were re-hospitalized for a medical issue unrelated to HF. Four patients declined to have a 
second scheduled MIHP in-home visit, one of whom expressed concern about duplication of services 
by a visiting nurse home health care program. Two additional patients did not undergo a second 
scheduled in-home visit, having been readmitted at the time of their scheduled home encounter. One 
patient received home intravenous diuretic therapy. Patient initiated ED evaluations were performed 
in 9 patients (45%), eight of whom were admitted. During Phase II, the incidence of 30-day all-cause 
readmissions was 40%. The incidence of HF readmissions was 20%. There were no adverse events. 
There were no deaths. 
Discussion 
We demonstrated the feasibility of integrating trained paramedics into the outpatient 
management of patients with HF. They performed scheduled and, when requested by a HF specialist, 
urgent home encounters for patients with heart failure. The “House Calls” program was designed to 
be a new option in the outpatient management of patients with heart failure. Urgent home encounters 
performed within 60 minutes of a request, represented a timely response to non-emergency 
problems. This response time contrasts with the usual medical response-time of hours to days for 
non-emergency issues. Signals of effectiveness for reducing early readmissions were observed. For 
example, in response to patient concerns, HF specialists requested urgent MIHP home assessments in 
20% of the enrolled patients. These in-home visits, facilitated by a dedicated Call Center, were 
performed within 30-60 minutes of a request. Only one of these urgent evaluations resulted in 
immediate transport to an ED. Urgent MIHP home assessments may provide a cost saving alternative 
to the usual process of referral to an emergency room and the associated high likelihood of re-
hospitalization(32). From the patient’s point of view, assessed by post-enrollment surveys, a timely 
MIHP in-home evaluation, with a link to their HF specialist, was perceived to be a valuable 
alternative to an ED visit or urgent office encounter. This process of care may significantly increase 
a patient’s “home-time”, an important patient-centered variable(33). Surveys of HF specialists and 
the participating patients revealed a positive perception of the paramedic “House Calls” program. 
 There is a very high rate of hospitalizations and readmissions during the terminal phase of 
advanced HF(34,35). Consistent with this expectation we observed a 30-day all-cause readmission 
rate of 40% in participants with Stage D HF. In contrast, the 30-day all-cause readmission rate 
among those with Stage C HF was 15%. Similar to previous reports(2,4,36,37), we observed a high 
incidence of early readmissions unrelated to HF. Factors contributing to these early readmissions 
have been identified, including medical comorbidities and noncompliance with medications. Efforts 
to maximize guideline-directed medical therapy during a scheduled MIHP home visit performed very 
early (2 days), late (15 days) and if needed, urgently, may be valuable. Face-to-face home encounters 
provide an opportunity to confirm medication compliance, as well as to identify non-cardiac factors 
which contribute to early readmissions. 
In support of the value of home-based care with paramedics, a large program in California 
reported their multi-community MIHP program reduced ambulance transports, ED visits and hospital 
admissions without adverse outcomes(38). Among their five MIHP pilot programs, all but one 
observed a significant reduction in 30-day readmissions. They observed a lower readmission rate 
when hospital systems provided at least one scheduled MIHP home visit compared to those only 
relying on a post-discharge phone call. The California MIHP program also reported significant cost 
savings, in part by avoiding financial penalties for excessive readmissions imposed by Medicare’s 










Although there were no adverse events in our small feasibility trial, a high-volume MIHP 
program may be associated with unforeseen risks. Inadequate training and suboptimal clinical skills 
may result in errors of judgement. Verbal and telecommunications between a paramedic and a HF 
specialist may be suboptimal and result in adverse events. Like observations reported after 
implementation of the Hospital Readmissions Reduction Program, trends of reduced risk adjusted 
readmissions maybe offset by an increase in risk adjusted mortality (39,40). Furthermore, in-home 
visits by MIHPs may be perceived as a duplication of service, conflicting with nurse home care 
programs. These concerns support the proposal for a randomized trial to confirm a MIHP program 
will be a safe as well as a cost-effective strategy to reduce early readmissions. 
There are multiple challenges to implementing a paramedic “House Calls” program. 
Successful programs will need to form partnerships with hospital networks and established home 
care services. Accessing electronic health data at the point of care is required for the success of a 
community paramedicine program(41). Our MIHP team did not have direct access to the patient’s 
EMR. This restriction limited their ability to confirm patient compliance with prescribed 
medications. Uploading home encounter documents into the patient’s EMR in the same location as 
clinic encounter documents will enhance the value of the information. MIHP programs will require 
financial support. Health care systems will need to cover the cost of paramedic training, as well as 
scheduled and urgent home services. Readmission risk scores may help identify HF subgroups with 
the highest risk of 30-day readmissions(42–45). Incorporating the stage of HF into these 
readmission risk scores may improve their predictive value and provide a better method to identify 
those who benefit from paramedic home evaluations. The increased cost of operationalizing a 
MIHP program may be offset by reducing unnecessary ED visits and their resultant 
hospitalizations (8,23–26). The Center for Medicare and Medicaid Innovation recently created a 
new payment model for ambulance services to provide triage and treatment, not just 
transportation(46). This program, referred to as ET3, aims to lower costs by reducing avoidable 
transports to the ED and unnecessary hospitalizations resulting from these transports. A MIHP 
program has the capability of performing triage and, with input from HF specialists, treatment at 
home. If MIHP programs document their value in multiple clinical scenarios, payors are more 
likely to be supportive. 
Conclusion 
 A process of care utilizing MIHPs performing scheduled and, if needed, urgent “House 
Calls” for patients with Stage C and Stage D HF is feasible. Guided by HF specialists, trained 
paramedics can perform home assessments and, if needed, provide acute medical interventions, 
possibly avoiding the need for ED evaluations and readmissions. We propose “House Calls” by 
trained paramedics, working within a MIHP program, may reduce 30-day readmissions and cost of 
care. A randomized trial is required to confirm this hypothesis. Trial design will need to control for 
the Stage of HF as well as other variables influencing early readmissions. Collaboration between 
health care systems and EMS organizations will be required. Cost analysis will need to include the 
educational as well operational costs of a paramedic program. 
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Table 1: Educational curriculum for MIHP 
Educational Plan Day 1 
Topic Objectives 
Population Health Overview The objective of this lecture is to 
familiarize the learner with the concept of 
population health. The lecture will focus 
on the current local and national 
environments in which hospitals and other 
entities function in relation to this topic. 
Social Needs Assessment and Management The objective of this lecture is to 
familiarize the learner’s understanding of 
the importance of social needs 
assessments, their impact on patient 
safety, wellbeing, and health outcomes. 
Mobile Integrated Health Paramedic Role 
Overview 
The objective of this lecture is to 
familiarize the learner with the concept of 
Mobile Integrated Healthcare. The lecture 
will outline examples of successful MIH 
programs and will help facilitate the 
learner’s understanding of where the MIH 
fits in the context of the entire healthcare 
system as well as this particular feasibility 
study. 
CHF Readmission Challenge and House 
Calls Feasibility Study Overview 
The objective of this lecture is to 
familiarize the learner with the challenges 
of CHF readmissions, implications to 
hospitals, EMS, and the patient. This 
lecture will also facilitate understanding of 
the House Calls feasibility study. 
Home Safety Assessment The objective of this lecture is to facilitate 
the learner’s understanding of a 
professional home risk assessment survey 
and the steps toward completing one.  
Key Clinical Findings in Heart Failure 
Patients 
The objective is to provide information 
that will guide paramedics and command 
physicians on appropriate indications for 
hospital admission for heart failure 
management.  
CHF Clinical Assessments and 
Management 
The objective of this lecture is to improve 
and expand the learner’s understanding of 
the management, assessment, and 
treatment of CHF patients. Topics 
included: CHF focused assessment, 
medication reconciliation, common lab 
values, and their significance during a 










Organization Structure The objective of this lecture is to facilitate 
the learner’s understanding of where they 
fit in the House Calls feasibility study 
organizational and reporting structure. 
Patient Visits The objective of this lecture is to facilitate 
the learner’s understanding of the 
following House Calls feasibility study 
processes: 
 General operational processes 
 Exams/assessments 
 Protocols 
 Referrals/Follow Up 
 Urgent “house call” process 
Communications The objective of this lecture and workshop 
is to facilitate the learner’s understand of 
crucual communications that will take 
place during their participation on the 
House calls feasibility study. The 
overview will focus on the following 
communication processes: 
 Communication with referring 
party 
 Communication with “MIHP 
Command Physician” 
 Communication with “EMS 
Medical Command Physician” 
 Communication with the 
Community Care Team (CCT) 
Documentation The objective of this lecture and workshop 
is to facilitate the learner’s understanding 
of the House Calls feasibilit study’s 
documentation platform (REDCap). The 
session will include an overview of the 
system and hands-on practice.  
Educational Plan Day 2: Scenarios 
Scenario Objectives 
2 day post discharge visit, no patient 
complaints 










Urgent house call, unexpected weight gain, 
referring provider advises patient to 
increase frequency of Lasix and/or other 
actions not requiring command physician. 
Test entire process. Test MIHP call out 
procedure. 
15 day post discharge visit, patient 
complaining of mild dyspnea on exertion. 
Referring provider requests MIHP 
administration of Lasix. 
Test entire process. Test MIHP to referring 
provider to EMS command physician 
communication process.  
Urgent house call. Visiting nurse on scene 
with patient experiencing unexpected 
weight gain and nocturnal dyspnea. 
(Would like to have actual visiting nurse 
representative.) Referring provider 
requests MIHP administration of Lasix.  
Test entire process. Test MIHP call out 
procedure. Test MIHP to referring provider 
to EMS command physician 
communicatoin process. 
Urgent house call. Mild dyspnea on 
exertion. MIHP arrives to find patient 
complaining of mild dyspnea at rest. 
Referring provider requests MIHP 
administration of Lasix. Communication 
via video conferencing.  
Test entire process. Test MIHP call out 
procedure. Test MIHP to referring provider 
to EMS command physician 













Table 2: Patient Characteristics 
 Stage C HF (n = 
20) 
Stage D HF (n = 
20) 
Age, median years (range) 70 (51-
88) 
67 (37-90) 
Female (%) 25 25 
Race   
White (%) 90 85 
Black (%) 0 10 
Other (%) 10 5 
HFr EF < 40 (%) 65 75 
 HFpEF > 40 (%) 35 25 
Diabetes mellitus (%) 75 50 
Chronic kidney disease   
Stage 1-2 (%) 31 12 
Stage 3-4 (%) 69 88 
Atrial fibrillation (%) 50 60 
ICD (%) 20 35 
Medications at discharge   
Beta blocker (%) 95 85 
ACEI/ARB (%) 70 35 
Mineralcorticoid antagonist (%) 40 50 
Hydralazine/nitrate (%) 15 20 
Sacubitril /valsartan (%) 10 25 
Furosemide or equivalent   
0-19 mg (%) 10 0 
20-39 mg (%) 20 26 
40-79 mg (%) 55 53 
>80 mg (%) 15 21 
ACEI/ARB = angiotensin converting enzyme inhibitors/angiotensin-receptor blockers 
EF = ejection fraction 
HFp EF = heart failure with preserved ejection fraction 
HFr EF = heart failure with reduced ejection fraction 











Table 3. Outcomes at 30 Days Post-Discharge 
 Stage C 
HF 
N-20 




House Calls by MIHP 
 Scheduled 
 Urgent 

















HF readmissions 1 (5) 4 (20) 5 (13) 
All-cause readmissions 3 (15) 8 (40) 11 (28) 
Unplanned clinic visits 4 (20) 4 (20) 8 (20) 
ED evaluations 
 MIHP initiated  














Admissions from ED 2 (10) 8 (40) 10 (25) 
Command Physician orders 3 (15) 1 (5) 4 (10) 
Adverse events 0 0 0 
Values are N (%) 
ED= emergency department 
HF = heart failure 
IV = intravenous 
MIHP = Mobile Integrated Health Paramedic 
Order = IV furosemide 
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